PubMed Health⌕ Search

Biomedical subjects

B Mukerji

Publications and source records attributed to B Mukerji.

At least 19 recordsLinked to original sources
PubMed2000

Right ventricular alterations in scuba divers: findings on electrocardiography and echocardiography.

BACKGROUND: Scuba diving imposes uncommon environmental stresses. This study assesses the effects of recreational scuba diving on the electrocardiogram (ECG) and echocardiogram and compares them with those of normal controls. METHODS: We studied 50 recreational scuba divers and 50 age-matched and sex-matched normal control subjects. Each subject had a medical history, physical examination, resting 12-lead ECG, and transthoracic echocardiogram. RESULTS: Electrocardiographic findings occurring significantly more frequently in scuba divers than in controls were sinus bradycardia, sinus arrhythmia, QRS duration (> or = 0.10 sec, right axis duration and R > or =S in V2. The mean right ventricular internal dimension (RVID) was significantly larger in divers than in controls. High-normal RVID (2.0 to 2.3 cm) occurred significantly more regularly in divers than in controls (10 vs 1). CONCLUSION: Recreational scuba diving produced right ventricular alterations characterized by chamber dilation and electrocardiographic signs of right ventricular hypertrophy, sinus bradycardia, and arrhythmia.

Adult↗
PubMed1997

Safety evaluation of wild apricot oil.

Wild apricot, a variety of Prunus armeniaca, grows in the hilly regions of India. The seeds yield 27% of kernels. The potential availability of the kernels is 40,000 tons/year and these yield 47% of oil. The oil has 94% unsaturated fatty acids, rich in oleic and linoleic acids. Systemic effects and nutritional quality of wild apricot oil (WAO) were assessed in a 13-wk feeding study in weanling albino rats using a diet containing 10% WAO as the sole source of dietary fat. A similar diet containing groundnut oil (GNO) was used as the control. WAO did not manifest any toxic potential. The food consumption, growth rate and food efficiency ratio of rats fed WAO were similar to those fed GNO. The digestibility of this oil was found to be comparable to that of GNO. There were no macroscopic or microscopic lesions in any of the organs that could be ascribed to WAO incorporation in the diet. The results of this study indicate that WAO could be used for edible purposes without any overt toxic signs or symptoms. However a long-term study may be needed to confirm its innocuousness further.

Animals↗
PubMed1995

The prevalence of rheumatologic disorders in patients with chest pain and angiographically normal coronary arteries.

The purpose of this study was to determine the prevalence of musculoskeletal disorders in patients with chest pain and angiographically normal coronary arteries. The authors studied 40 consecutive patients with chest pain presenting at an Internal Medicine Clinic who had undergone coronary angiography and were found to have < 30% stenosis of all major coronary arteries. Patients with any known noncardiac cause of chest pain were excluded from the study. Each patient underwent a complete rheumatologic examination with x-rays and blood tests when indicated. The diagnosis of fibromyalgia was based on the presence of at least eight paired tender points. The diagnosis of costochondritis was made when palpation of the costal cartilages elicited tenderness. In the normal coronary artery group, 30% of the patients had fibromyalgia and 10% had costochondritis. In the control group of 40 patients with coronary artery disease, only 1 patient had fibromyalgia and none had costochondritis (P < 0.04). Other rheumatologic disorders were uncommon, with no statistical difference between the two groups. The authors conclude that many patients with chest pain and angiographically normal coronary arteries suffer from rheumatologic disorders with fibromyalgia being the most common.

Adult↗
PubMed1994

Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension.

Efforts aimed at assessing pharmacotherapy of pulmonary arterial hypertension (PHT) have largely focused on patients with primary PHT, PHT associated with selected connective tissue diseases, and various forms of hypoxic secondary PHT. Part I of this review discusses the value and limitations of a wide variety of vasodilator drugs, oxygen, and warfarin in the treatment of primary PHT with special reference to their effects on pulmonary and systemic hemodynamics, functional capacity, and survival.

Acetylcholine↗
PubMed1994

The challenge of sensorineural hearing loss in rheumatoid arthritis.

Patients with rheumatoid arthritis are exposed to a variety of pharmacologic agents capable of causing sensorineural hearing loss. We describe such a patient who was eventually found to have an acoustic neuroma. The case illustrates the difficulty of diagnosing acoustic neuroma and the need for a high index of suspicion when unilateral hearing loss is detected. The evaluation of patients with sensorineural hearing loss is discussed.

Anti-Inflammatory Agents, Non-Steroidal↗
PubMed1993

When the lungs are involved by connective tissue disease.

Pulmonary involvement by a connective tissue disease can result in clinically important complications. Pathogenic mechanisms vary from granulomatous reaction and interstitial inflammation to primary vasculitis and immune complex-mediated disease. Understanding the pulmonary complications of connective tissue diseases is challenging in that several distinct patterns of involvement are associated with the same disease but the same lung abnormalities are found with several different diseases. Early recognition and treatment of pulmonary involvement may offer the patient a better chance of recovery from serious conditions that often carry a grim prognosis if undetected.

Arthritis, Rheumatoid↗
PubMed1993

Undifferentiated, overlapping, and mixed connective tissue diseases.

Undifferentiated connective tissue disease (UCTD) is a term used by many rheumatologists to define a group of diffuse connective tissue disorders that lack definitive characteristics of any particular well-defined disorder. Overlapping connective tissue disease is often used interchangeably with UCTD but they both refer to diseases that are in evolution before all the characteristic clinical and laboratory symptoms are manifested. However, the clinical features of some of the overlapping connective tissue diseases appear to be better defined. The classical one is mixed connective tissue disease, where features of systemic lupus erythematosus, progressive systemic sclerosis, and polymyositis may exist together with a positive anti-extractable nuclear antibody and high titers of anti-ribonuclear protein antibody. This review attempts to clarify the confusion between these terms. The problems in the clinical and laboratory diagnosis of common connective tissue diseases that coexist are addressed and treatment options discussed. The long-term implications of making a diagnosis of a definitive connective tissue disease before all the required criteria are met should be kept in mind because the patient may never develop the disease and yet be subjected to psychological, social, and economic hardships.

Humans↗
PubMed1992

Short- and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease.

To assess the pulmonary and systemic hemodynamic effects of oral captopril in patients with connective tissue disease and pulmonary hypertension, we performed right heart catheterization in eight patients with diffuse systemic sclerosis, the CREST syndrome, or mixed connective tissue diseases prior to and immediately following administration of captopril (dose range 12.5 to 50.0 mg, short-term study). Four of these patients underwent repeat right heart catheterization after three to six months of oral captopril therapy (long-term study). In the short-term study, oral captopril produced a significant decrease in mean pulmonary vascular resistance from 6.2 +/- 3.6 to 4.6 +/- 3.8 units (p < 0.01). This was accompanied by a significant decrease in mean pulmonary artery pressure, mean blood pressure, mean systemic vascular resistance and a significant increase in cardiac output. Similar changes in pulmonary hemodynamics were noted in the long-term study. Thus, oral captopril is capable of producing an acute and sustained reduction in pulmonary vascular resistance in patients with pulmonary hypertension associated with the aforementioned connective tissue diseases.

Adult↗
PubMed1991

Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.

Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics. Each patient underwent right-sided cardiac catheterization just before nifedipine administration. Thereafter, oral nifedipine was administered in 10 mg increments every 90 minutes until pulmonary vascular resistance normalized or a total dose of 30 mg was achieved. Hemodynamic measurements were obtained at 30-minute intervals for 3 hours, then hourly for 9 hours (acute study). Hemodynamic studies were repeated 3 to 6 months after the initial catheterization with the minimum dose of oral nifedipine (administered every 8 hours) required to achieve maximal reduction of pulmonary vascular resistance in the acute study (long-term study). In the acute study, oral nifedipine produced a significant decrease in mean pulmonary vascular resistance from 6.3 +/- 3.8 to 4.3 +/- 3.6 U (p less than 0.001). Similar changes in pulmonary vascular resistance were noted in the long-term study (n = 6). The results indicate that oral nifedipine is capable of producing an acute and sustained reduction in pulmonary vascular resistance in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.

Adult↗
PubMed1989

Cardiovascular changes in athletes.

Athletic training commonly increases left ventricular and diastolic volume and left ventricular wall thickness within weeks to months of the beginning of vigorous conditioning. Bradycardia is usual and a third heart sound is frequently audible. A systolic heart murmur is present in 30 to 50 percent of athletes. An increased PR interval, widening of the QRS complex and repolarization alterations are among the most common electrocardiographic abnormalities. Cardiomegaly and a globular heart are characteristically seen on chest radiographs.

Adaptation, Physiological↗